Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE studyMiguel Á. Sanz, Montserrat Rovira, Juan Besalduch et al.|Current Medical Research and Opinion|2005Cited by 18
Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/<i>TCF3‐PBX1</i> treated with measurable residual disease‐oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades et al.|British Journal of Haematology|2021Cited by 7